Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on MorphoSys AG’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
14 Jun 2022 | MorphoSys and Human Immunology Biosciences (HIBio) Enter into Licensing Agreement for MOR210 | Licensing Agreement |
Human Immunology Biosciences Inc
|
MorphoSys AG |
14 Jun 2022 | MorphoSys and Human Immunology Biosciences (HIBio) Enter into Licensing Agreement for Felzartamab | Licensing Agreement |
Human Immunology Biosciences Inc
|
MorphoSys AG |
13 Jun 2022 | Pfizer, MorphoSys and Incyte to Enter into Collaboration | Partnership | - |
Pfizer Inc Incyte Corp
MorphoSys US Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer